Hao-Wei Chu

Prof. Hao-Wei Chu

Chang Gung University
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 September 2019 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
HCHao-Wei Chu
Hao-Wei Chu
KCKai-Ping Chang
Kai-Ping Chang
CHChia-Wei Hsu
Chia-Wei Hsu
ICIan Yi-Feng Chang
Ian Yi-Feng Chang
HLHao-Ping Liu
Hao-Ping Liu
CWChih-Ching Wu
Chih-Ching Wu
Oral cavity squamous cell carcinoma (OSCC) is one of the most common cancers worldwide. In Taiwan, OSCC is the fifth leading cause of cancer-related mortality and leads to 2800 deaths per year. The poor outcome of OSCC patients is principally ascribed to the fact that this disease is often advanced at the time of diagnosis, suggesting that early detection of OSCC is urgently needed. Analysis of cancer-related body fluids is one promising approach to identify biomarker candidates of cancers. To identify OSCC biomarkers, salivary proteomes of OSCC patients, individuals with oral potentially malignant disorders (OPMDs), and healthy volunteers were comparatively profiled with isobaric tags for relative and absolute quantitation (iTRAQ)-based mass spectrometry (MS). The salivary levels of 67 and 18 proteins in the OSCC group are elevated and decreased compared with that in the noncancerous group (OPMD and healthy groups), respectively. The candidate biomarkers were further selected using the multiple reaction monitoring (MRM)-MS and validated with the immunoassays. More importantly, the higher salivary level of three proteins, complement factor H (CFH), fibrinogen alpha chain (FGA), and alpha-1-antitrypsin (SERPINA1) was correlated with advanced stages of OSCC. Our results indicate that analysis of salivary proteome is a feasible strategy for biomarker discovery, and the three proteins are potential salivary markers for OSCC diagnosis.

23 February 2018 in Proteomics
Verified
Journal Article
Closed access
MLMei-Hui Lin
Mei-Hui Lin
CLChi-Chun Li
Chi-Chun Li
JSJwu-Ching Shu
Jwu-Ching Shu
HCHao-Wei Chu
Hao-Wei Chu
CLChao-Chin Liu
Chao-Chin Liu
CWChih-Ching Wu
Chih-Ching Wu

2 September 2021 in Viruses
Verified
Journal Article
Open access
PDF file
HCHao-Wei Chu
Hao-Wei Chu
BSBidyadhar Sethy
Bidyadhar Sethy
PHPei-Wen Hsieh
Pei-Wen Hsieh
JHJim-Tong Horng
Jim-Tong Horng
The Michael addition reaction is a spontaneous and quick chemical reaction that is widely applied in various fields. This reaction is performed by conjugating an addition of nucleophiles with α, β-unsaturated carbonyl compounds, resulting in the bond formation of C-N, C-S, C-O, and so on. In the development of molecular materials, the Michael addition is not only used to synthesize chemical compounds but is also involved in the mechanism of drug action. Several covalent drugs that bond via Michael addition are regarded as anticarcinogens and anti-inflammatory drugs. Although drug development is mainly focused on pharmaceutical drug discovery, target-based discovery can provide a different perspective for drug usage. However, considerable time and labor are required to define a molecular target through molecular biological experiments. In this review, we systematically examine the chemical structures of current FDA-approved antiviral drugs for potential Michael addition moieties with α, β-unsaturated carbonyl groups, which may exert an unidentified broad-spectrum inhibitory mechanism to target viral or host factors. We thus propose that profiling the targets of antiviral agents, such as Michael addition products, can be achieved by employing a high-throughput LC-MS approach to comprehensively analyze the interaction between drugs and targets, and the subsequent drug responses in the cellular environment to facilitate drug repurposing and/or identify potential adverse effects, with a particular emphasis on the pros and cons of this shotgun proteomic approach.

22 December 2018 in Proteomics – Clinical Applications
Verified
Journal Article
Closed access
PDF file
CWChih-Ching Wu
Chih-Ching Wu
SCShih-Chieh Chang
Shih-Chieh Chang
GZGuang-You Zeng
Guang-You Zeng
HCHao-Wei Chu
Hao-Wei Chu
YHYenlin Huang
Yenlin Huang
HLHao-Ping Liu
Hao-Ping Liu